Tinkering with vaccine dosage and timing makes a mockery of clinical trials
What happens when the protocols aren’t followed? What about the risk of a lower level of immunity? Or future mutations with global implications?
05 January 2021 - 16:55
Every country that is imposing varying degrees of lockdowns because of rising coronavirus infection rates — as the UK did on Monday — is trying to reduce the burden of the disease on its population, health-care systems and economy. The best solution, of course, is vaccines, and three shots have proved in trials to offer protection against disease. That’s assuming they are administered based on data generated from clinical trials.
But what happens when the protocols aren’t followed? ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.